Impact of Achieved Blood Pressures on Mortality Risk and End-Stage Renal Disease Among a Large, Diverse Hypertension Population

Cutler, 2008, Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004, Hypertension, 52, 818, 10.1161/HYPERTENSIONAHA.108.113357 Egan, 2010, US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008, JAMA, 303, 2043, 10.1001/jama.2010.650 Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 Whelton, 2002, Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program, JAMA, 288, 1882, 10.1001/jama.288.15.1882 Klag, 1996, Blood pressure and end-stage renal disease in men, N Engl J Med, 334, 13, 10.1056/NEJM199601043340103 1967, Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg, JAMA, 202, 1028, 10.1001/jama.1967.03130240070013 1991, Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group, JAMA, 265, 3255, 10.1001/jama.1991.03460240051027 Turnbull, 2008, Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials, BMJ, 336, 1121, 10.1136/bmj.39548.738368.BE 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group, BMJ, 317, 703, 10.1136/bmj.317.7160.703 Hansson, 1998, Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group, Lancet, 351, 1755, 10.1016/S0140-6736(98)04311-6 Julius, 2004, Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial, Lancet, 363, 2022, 10.1016/S0140-6736(04)16451-9 Staessen, 1997, Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators, Lancet, 350, 757, 10.1016/S0140-6736(97)05381-6 Staessen, 2000, Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials, Lancet, 355, 865, 10.1016/S0140-6736(99)07330-4 Cushman, 2010, Effects of intensive blood-pressure control in type 2 diabetes mellitus, N Engl J Med, 362, 1575, 10.1056/NEJMoa1001286 Appel, 2010, Intensive blood-pressure control in hypertensive chronic kidney disease, N Engl J Med, 363, 918, 10.1056/NEJMoa0910975 2008, Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS), Hypertens Res, 31, 2115, 10.1291/hypres.31.2115 Ogihara, 2010, Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study, Hypertension, 56, 196, 10.1161/HYPERTENSIONAHA.109.146035 Benavente, 2013, Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial, Lancet, 382, 507, 10.1016/S0140-6736(13)60852-1 Wright, 2002, Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial, JAMA, 288, 2421, 10.1001/jama.288.19.2421 Iseki, 1997, Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients, Kidney Int, 51, 1212, 10.1038/ki.1997.165 Port, 1999, Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients, Am J Kidney Dis, 33, 507, 10.1016/S0272-6386(99)70188-5 Kovesdy, 2013, Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney DiseaseA Cohort Study, Annals of Internal Medicine, 159, 233, 10.7326/0003-4819-159-4-201308200-00004 Yusuf, 2008, Telmisartan, ramipril, or both in patients at high risk for vascular events, N Engl J Med, 358, 1547, 10.1056/NEJMoa0801317 Bangalore, 2010, J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial, Eur Heart J, 31, 2897, 10.1093/eurheartj/ehq328 Ruggenenti, 2005, Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial, Lancet, 365, 939, 10.1016/S0140-6736(05)71082-5 Verma, 2011, Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study, Eur Heart J, 32, 2135, 10.1093/eurheartj/ehr066 Koebnick, 2012, Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data, Perm J, 16, 37, 10.7812/TPP/12-031 Bhandari, 2011, 25-hydroxyvitamin D levels and hypertension rates, J Clin Hypertens (Greenwich), 13, 170, 10.1111/j.1751-7176.2010.00408.x Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006 Sim, 2013, Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system, Mayo Clin Proc, 88, 1099, 10.1016/j.mayocp.2013.06.017 Sim, 2011, Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system, Am J Hypertens, 25, 379, 10.1038/ajh.2011.216 Sim, 2014, Systemic implementation strategies to improve hypertension: the Kaiser Permanente Southern California experience, Can J Cardiol, 30, 544, 10.1016/j.cjca.2014.01.003 Go, 2004, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 351, 1296, 10.1056/NEJMoa041031 Zanchetti, 2010, Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve, Eur Heart J, 31, 2837, 10.1093/eurheartj/ehq281 Perry, 2000, Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP), JAMA, 284, 465, 10.1001/jama.284.4.465 Cooper-DeHoff, 2010, Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease, JAMA, 304, 61, 10.1001/jama.2010.884 DeFelice, 2008, The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis, J Hum Hypertens, 22, 659, 10.1038/jhh.2008.51 Diao, 2012, Pharmacotherapy for mild hypertension, Cochrane Database Syst Rev, 8, CD006742 James, 2014, 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8), JAMA, 311, 507, 10.1001/jama.2013.284427 Romero-Corral, 2006, Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies, Lancet, 368, 666, 10.1016/S0140-6736(06)69251-9 Diehr, 2013, Decline in health for older adults: five-year change in 13 key measures of standardized health, J Gerontol A Biol Sci Med Sci, 68, 1059, 10.1093/gerona/glt038